Fortress Biotech, Inc.FBIONASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P5
Near historical low
vs 5Y Ago
-8.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -55.07% |
| Q2 2025 | 51.02% |
| Q1 2025 | -3.96% |
| Q4 2024 | 21.49% |
| Q3 2024 | 5.62% |
| Q2 2024 | 16.06% |
| Q1 2024 | -20.66% |
| Q4 2023 | 4.04% |
| Q3 2023 | -11.07% |
| Q2 2023 | -3.56% |
| Q1 2023 | -7.43% |
| Q4 2022 | -9.17% |
| Q3 2022 | 3.76% |
| Q2 2022 | 10.57% |
| Q1 2022 | -2.48% |
| Q4 2021 | 21.23% |
| Q3 2021 | 14.65% |
| Q2 2021 | 10.49% |
| Q1 2021 | 15.38% |
| Q4 2020 | -1.16% |
| Q3 2020 | 6.41% |
| Q2 2020 | -6.85% |
| Q1 2020 | 8.30% |
| Q4 2019 | -0.06% |
| Q3 2019 | 6.67% |
| Q2 2019 | -0.26% |
| Q1 2019 | 405.55% |
| Q4 2018 | -136.20% |
| Q3 2018 | -6.68% |
| Q2 2018 | -32.07% |
| Q1 2018 | 1432.62% |
| Q4 2017 | -92.19% |
| Q3 2017 | -0.99% |
| Q2 2017 | 12.04% |
| Q1 2017 | 48.49% |
| Q4 2016 | 9.97% |
| Q3 2016 | 2.65% |
| Q2 2016 | 8.86% |
| Q1 2016 | 10.04% |
| Q4 2015 | 1.11% |